Personal Oncology
Nanjing
About Personal Oncology
Personal Oncology specializes in the diagnosis and treatment of tumors. It has developed a PDTX technology (FASTPDTX) that has reached the clinical use level.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $31.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2022)
- Website: personaloncology.cn
- Phone: +86-025-86629906
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Canonical: https://fsome.com/organization/personal-oncology-38249 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.